Imperial Recognized as 2026 National Best and Brightest Company to Work For! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Category:

Clinical Trial Business Insights

    Clinical Trial Business InsightsParticipant Engagement

    An Inside Look at Privacy Laws

    by Melynda Geurts January 2, 2014
    written by Melynda Geurts

    We talk a lot about privacy and how we can and cannot reach the public about clinical trials. What is privacy? By definition, privacy is “the quality or state of being apart from company or observation; seclusion or freedom from unauthorized intrusion.” So what does this mean to us in the clinical research industry?  It’s like playing a game of chess. Strategic positioning can occur if the proper guidelines (or rules) are followed.

    Interpretation of privacy tends to be varied, vague and gray. Each country /state has its own privacy laws. Some laws are explicit in how they are to be followed and others are not. In the countries where it’s not so explicit, you’ll find that using external recruitment efforts are allowed from a regulatory perspective but culturally you will run into challenges.

    Recruitment and retention specialists should be viewed as educators. We find that ongoing education among research staff is just as important, if not more important, in hurdling the privacy challenges.  This is most important in ROW countries where physicians continue to have a strong influence over their patients’ treatment options. You still see this influence in the United States, but on a more limited basis.

    When developing an international recruitment and/or retention program, use your historical metrics from previous studies and programs, feedback from research staff and regulatory links (shown below) for guidance as to what strategies can and cannot be used. The cultural acceptability will have to come from your past experiences or that of your recruitment vendor.

    Imperial has managed more than 250 projects and more than 75 percent were international in scope. We have yet to have a service rejected due to regulations. It’s just taken time to educate and cultivate relationships with the sites. Misconceptions about recruitment and retention continue. But once sites have a full understanding of the service, they buy in.

    Just remember that the majority of all privacy laws represent intellectual property and not that of an individual.

    January 2, 2014 0 comments
    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Avoiding Common Pitfalls in Multinational Clinical Trials

    by Dan McDonald December 17, 2013
    by Dan McDonald December 17, 2013

    By Dan McDonald Multinational clinical trials are challenging. The international industry is rapidly maturing, but horror stories are still common: “Our study drug is melting in a hot locker in customs, and I can’t get hold of anyone.” “Sure, that country enrolled like gangbusters, but …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Looking Back to Move Forward

    by Steve Swanson December 17, 2013
    by Steve Swanson December 17, 2013

    As 2013 rapidly comes to a close, we reflect back, analyze and establish forward 2014 goals for our organization. Reflecting back provides us with more awareness of trends affecting all of us in the life-sciences industry. Consolidation and outsourcing have continued, as has increased awareness …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Timeline Management: In Search of the 25th Hour

    by Hope Cullen November 22, 2013
    by Hope Cullen November 22, 2013

    Do you ever feel there isn’t enough time in the day to get everything done? In the life-science industry, we are forever trying to achieve completion in time for the next site initiation visit or first patient in. Ensuring clinical trial materials are on-site in time can be …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Site motivation. Want to learn more? Get closer.

    by Melynda Geurts October 25, 2013
    by Melynda Geurts October 25, 2013

    We’ve all heard these metrics — 31 percent of Phase 2 and 30 percent of Phase 3 trials are running longer. And site staff members are over-resourced. Time delays demotivate site performance. There are three pieces to the puzzle to make clinical trials successful, including pharmaceutical/biotechnology companies, …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Site Solutions Summit: Reflections & Visions

    by Steve Swanson October 18, 2013
    by Steve Swanson October 18, 2013

    Having recently returned from this year’s Site Solutions Summit, it seems appropriate to share some reflections. Being on the Global Impact Partners Advisory Board for the Society for Clinical Research Sites (SCRS) provides a unique view into the planning and purpose of the summit. I can say …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Things to Consider When Shipping Internationally

    by Hope Cullen October 3, 2013
    by Hope Cullen October 3, 2013

    As industry professionals, we spend a lot of time and energy writing, designing and producing materials in support of clinical trials. During this process, shipping materials to their final destination is often an afterthought, with address information provided at the last minute. This is not …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Lost Art of Face-to-Face Meetings

    by Melynda Geurts August 23, 2013
    by Melynda Geurts August 23, 2013

    Physiologically speaking, a mental picture is worth a thousand words. So, isn’t it interesting that we’ve taken a social society by nature and applied modern technology to make business practices more efficient? And yet, we are skeptical of individuals who choose not to post their …

    0 FacebookTwitterLinkedinEmail
  • 1
  • …
  • 18
  • 19
  • 20

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email Rss

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Clinical Trial Supplies and Equipment (44)
  • Clinical Trial Business Insights (198)
  • Clinical Trial Materials Development and Printing (55)
  • Participant Engagement (113)
  • Translation of Clinical Trial Materials (21)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribetoourblogandgetthelatestupdates,insights,andindustrytrendsdeliveredstraighttoyourinbox.Stayinformedandnevermissapost.

 

 


Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace